System design solutions for high volume immunoassay analysis

Journal of Clinical Ligand Assay

Volumn 22, Issue 2, 1999, Pages 184-193

  Day, Rodney G ^a   Horschke, William A ^a   Hallahan, Mary Theresa ^a   Jackson, Thomas ^a   Williams, Julie S ^a  

^a BAYER CORPORATION   (United States)

Author keywords

Automated immunoassay instruments; Chemiluminescence

Indexed keywords

ACCURACY; ARTICLE; AUTOANALYSIS; CHEMOLUMINESCENCE; IMMUNOASSAY; LABORATORY TEST; PATIENT MONITORING;

EID: 0032847217     PISSN: 10811672     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Pomerantz P, LoSciuto L: Results of the Clinical Laboratory Management Association's industry trends survey. Clin Lab Manage Rev 1996;10(6):597-605.
2. Travers, EM: Laboratory manager's financial handbook. Clin Lab Manage Rev 1996;10(1):56-66.
3. Felder, RA: Overview and challenges, in Kost, GJ (ed): Handbook of Clinical Automation, Robotics, and Optimization. New York: John Wiley & Sons, Inc., 1996, p. 18.
4. Pearlman ES, Swiss S, Stauffer J, et al: Selection factors in the choice of immunoassay technology: Implementing technology in the new era. Clin Lab Manage Rev 1998;12(1):27-30.
5. Chiron Diagnostics Corporation: Reference Manual, ACS:Centaur Automated Chemiluminescence System, East Walpole, MA, 1997.
6. Williams JS: System performance fingerprinting. Med Lab Observ 1997;29(8):84-85.
7. Williams JS, Clayborne M, Dickinson B, et al: Productivity of the AxSYM, ACS: 180, and ACS:Centaursystems compared. Clin Chem 1997;43(6):S133.
8. Girgensohn S, Liedtke R, Baiser G, et. al.: Performance of the ACS:Centaur high-capacity random-access immunoassay system. Clin Lab 1997;43:975-983.
9. Taylor L, Day R, Sleights P: Productivity evaluation of the ACS:Centaur. Quimica Clinica 1998;17(2):151.
10. Geyer SJ, Moore SJ, Michetti DJ: A study of the potential impact of the ACS:Centaur in a hospital core laboratory. Clin Chem 1998;44(6):A57.